TSHA
Conviction 47HealthcareScan · Thu, Sep 24, 2026Taysha Gene Therapies, Inc. (TSHA) closed at $4.80 (-2.24%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 91, -31.2% from its 52-week high, -8.6% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TSHA
Insider activity
SEC Form 4 transactions in TSHA · open-market 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Nagendran Sukumar President and Head of R&D · Common Stock · 2026-07-10 | Sell | 200K | $1.2M | 2026-07-10 | 2026-07-10 |
Stalfort John A III Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Donenberg Phillip B. Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Stalfort John A III Director · Common Stock · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-02 |
Long Alison S Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Long Alison S Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Stalfort John A III Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Sepp-Lorenzino Laura Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Donenberg Phillip B. Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Sepp-Lorenzino Laura Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
SEC filings
EDGAR filings in TSHA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.